CNTB

0.59006.08%
JI

Jean I. Liu

Independent Director

Ms. Jean I. Liu, J.D., M.S., serves as Board Member of Angarus Therapeutics, Inc. Ms. Liu Served has Chief Legal Officer of Seagen Inc. From December 2021 to December 14, 2023 and its Corporate Secretary From November 2014 to December 14, 2023. Ms. Liu serves as Independent Director of Erasca, Inc. since April 2022. Ms. Liu serves as Independent Director of Connect Biopharma Holdings Limited from August 2021. She served as an Executive Vice President of Legal Affairs and General Counsel of Seagen Inc. (formerly known as Seattle Genetics, Inc.) since November 2014 until December 2021. Ms. Liu served as Vice President, General Counsel and Secretary at Halozyme Therapeutics, Inc. from November 2011 to November 7, 2014. Ms. Liu served as Chief Legal Officer of DURECT Corporation until January 2011, Senior Vice President of Legal since February 2003, Vice President of Legal from October 1998 to February 2003, Secretary since March 2004 and its General Counsel since February 1999. She holds Legal positions at DURECT Corporation from 1998 to 2011. Prior to Durect, she served as an Attorney at Venture Law Group from May 1997 to October 1998 and Pillsbury Madison & Sutro LLP from September 1993 to May 1997. She has professional experience advising pharmaceutical and biotechnology companies on a broad range of corporate, intellectual property, compliance. She is a Member of the State Bar of California and is admitted to practice before the United States Patent and Trademark Office. Ms. Liu holds a B.S. in Cellular & Molecular Biology from University of Michigan, an M.S. in Biology from Stanford University and a J.D. from Columbia University School of Law.

Positions